Evidence map›Paper›PMID 40162319›Full record

ArticleFrontiers in endocrinology2025

Antagonistic effects of smoking and maternal glycemia on fetal growth: a retrospective study among 13,958 pregnant French women.

Emmanuel Cosson, Lionel Carbillon, Sopio Tatulashvili, Hélène Bihan, Eric Vicaut, Ines Barka, Sara Pinto, Imen Rezgani, Mohamed Zerguine, Jean-Jacques Portal and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emmanuel CossonAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Lionel CarbillonAssistance Publique - Hôpitaux de Paris (AP-HP), Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, Fédération Hospitalo-Universitaire "Early Identification of Individual trajectories in neuro-developmental disorders" (I2D2), Department of Perinatology and Gynecology, Bondy, France.
Sopio TatulashviliAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Hélène BihanAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Eric VicautAssistance Publique - Hôpitaux de Paris (AP-HP), Unité de Recherche Clinique St-Louis-Lariboisière, Université Denis Diderot, Paris, France.
Ines BarkaAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Sara PintoAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Imen RezganiAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Mohamed ZerguineAssistance Publique - Hôpitaux de Paris (AP-HP), Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Department of Endocrinology-Diabetology-Nutrition, Centre de Recherche en Nutrition Humaine - Ile de France (CRNH-IdF), Centre Spécialisé de l'Obésite Île-de-France Nord, Bobigny, France.
Jean-Jacques PortalAssistance Publique - Hôpitaux de Paris (AP-HP), Unité de Recherche Clinique St-Louis-Lariboisière, Université Denis Diderot, Paris, France.
Marion FermautAssistance Publique - Hôpitaux de Paris (AP-HP), Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, Fédération Hospitalo-Universitaire "Early Identification of Individual trajectories in neuro-developmental disorders" (I2D2), Department of Perinatology and Gynecology, Bondy, France.
Jardena J PuderObstetric Service, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Amélie BenbaraAssistance Publique - Hôpitaux de Paris (AP-HP), Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, Fédération Hospitalo-Universitaire "Early Identification of Individual trajectories in neuro-developmental disorders" (I2D2), Department of Perinatology and Gynecology, Bondy, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Smoking and hyperglycemia first diagnosed during pregnancy (H1inP) have opposing effects on fetal growth. The aim of this study was to explore adverse pregnancy outcomes, particularly fetal growth, according to the smoking and H1inP status. Methods: We included 13,958 women from a large French dataset (2012-2018). Using multivariable regression analyses, we retrospectively evaluated the risk of large-for-gestational-age (LGA) babies and other adverse outcomes according to the H1inP and smoking status in four groups: no H1inP/non-smoker (group A: Results: The rates of LGA were 8.9%, 4.0%, 14.6%, and 8.7% in groups A, B, C, and D, respectively (global ANOVA Discussion: Smoking among women with H1inP could mask the risk of maternal hyperglycemia for LGA babies. This could provide a false sense of security for women with H1inP who smoke, particularly when assessing for LGA alone, but these women still face other risks to their health, such as hypertensive disorders and the health of the fetus.

Indexed as

Blood GlucoseFetal DevelopmentFetal MacrosomiaHyperglycemiaPregnancy ComplicationsSmokingAdultFemaleFranceHumansInfant, NewbornPregnancyPregnancy OutcomeRetrospective StudiesBlood Glucosebirthweightcigarettesdiabetes in pregnancygestational diabetes mellitushyperglycemia in pregnancypregnancy outcomessmokingtobacco

Identifiers

PMID40162319
PMCPMC11949801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.